Newsroom.
GCAM, the US Based Plasma Collection Division of GC Biopharma, Opens a New Collection Center in Texas
Fullerton, CA Jan 10, 2020 - GCAM, Inc., a US-based plasma collection company, announced that it has added additional plasma collection centers located in Edinburg, Texas. With the newest additions, GCAM now operates 12 plasma donation centers nationwide.
“Two additional plasma collection centers will be established this year,” said Sung Ick Park, GCAM CEO. “We are helping local economies by bringing jobs to the communities and by providing opportunities for plasma donors.”
Human plasma is an essential source for products in treating patients suffering from many different life-threatening diseases and conditions, including immune deficiencies, hemophilia, and other blood disorders.
GCAM is a member of the GC family of companies. GC Biopharma is one of the largest protein therapy manufacturers in the world. GCAM collects high-quality source plasma for GC Biopharma and other plasma fractionators. GCAM can collect up to 650,000 liters of source plasma annually.
About GCAM
GCAM, Inc., headquartered in Fullerton, CA, was established in 2009 and is a member of South Korea’s GC group of companies. GCAM operates source plasma centers in the United States. Its sister company, GC Biopharma, operates biopharmaceutical businesses on a global scale with a state-of-the-art plasma fractionation facility in Montreal, Quebec.
This release includes forward-looking statements, which express the current beliefs and expectations of GCAM’s management. Such statements speak only as of the date on which they occur, and the company undertakes no obligation to update or revise any forward-looking statement, whether because of new information, future events, or otherwise.